Odyssey Therapeutics Inc.
Organization details
- Legal name
- Odyssey Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Boston
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ODTX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001882782
- EIN
- 86-3384382
Board of directors
-
Aranicki Ksenija Pavletic · DirectorSince 2026
-
Carolyn Ng · DirectorSince 2026
-
Gary D. Glick · Director · See RemarksSince 2026
-
Ian F. Smith · DirectorSince 2026
-
Jeffrey M. Leiden · DirectorSince 2026
-
Nan (Ln) Li · DirectorSince 2026
-
Ourania Tatsis · DirectorSince 2026
-
Paulina Hill · DirectorSince 2026
-
Shelley Chu · DirectorSince 2026
- Since 2026
-
Valerie Odegard · DirectorSince 2026
Board connections
4 of this board's directors also sit on 11 other boards. 11 are in the same sector.
-
Bicara Therapeutics Inc. Same sectorvia Carolyn Ng
-
BioMarin Pharmaceutical Inc. Same sectorvia Timothy P. Walbert
-
Century Therapeutics Inc. Same sectorvia Timothy P. Walbert
-
Foghorn Therapeutics Inc. Same sectorvia Ian F. Smith
-
Kardigan Inc. Same sectorvia Timothy P. Walbert
-
Latigo Biotherapeutics Inc. Same sectorvia Timothy P. Walbert
-
Mirum Pharmaceuticals Inc. Same sectorvia Timothy P. Walbert
-
Sagimet Biosciences Inc. Same sectorvia Timothy P. Walbert
-
Solid Biosciences Inc. Same sectorvia Ian F. Smith
-
Stoke Therapeutics Inc. Same sectorvia Ian F. Smith
-
Vertex Pharmaceuticals Incorporated Same sectorvia Jeffrey M. Leiden
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $75,319,986
- 9 purchases by 7 insiders
- Sold, last 12 months
- $32,040
- 3 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 11, 2026 | James G. Coulter Former 10% Owner | Other | +423,111 | — | — |
| May 11, 2026 | Simeon George 10% owner | Derivative conversion | +474,048 | — | — |
| May 11, 2026 | Nan (Ln) Li Director | Derivative conversion | +1,709,543 | — | — |
| May 11, 2026 | Shelley Chu Director | Open-market purchase | +11,111 | $18.00 | $199,998 |
| May 11, 2026 | Gary D. Glick Director, Officer (See Remarks) | Derivative conversion | +27,386 | — | — |
| May 11, 2026 | Opipari Anthony W. Officer (See Remarks) | Derivative conversion | +6,965 | — | — |
| May 11, 2026 | James G. Coulter Former 10% Owner | Other | −2,351 | $18.00 | $42,318 |
| May 11, 2026 | Simeon George 10% owner | Derivative conversion | +139,366 | — | — |
| May 11, 2026 | Jeffrey M. Leiden Director | Derivative conversion | +28,698 | — | — |
| May 11, 2026 | Nan (Ln) Li Director | Open-market purchase | +1,111,111 | $18.00 | $19,999,998 |
| May 11, 2026 | Opipari Anthony W. Officer (See Remarks) | Option exercise | +541 | — | — |
| May 11, 2026 | James G. Coulter Former 10% Owner | Derivative conversion | +1,880,497 | — | — |
| May 11, 2026 | Simeon George 10% owner | Derivative conversion | +59,692 | — | — |
| May 11, 2026 | Jeffrey M. Leiden Director | Option exercise | +2,963 | — | — |
| May 11, 2026 | Opipari Anthony W. Officer (See Remarks) | Shares withheld for tax | −4 | $18.00 | $72 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Odyssey Therapeutics Inc.
How many directors are on Odyssey Therapeutics Inc.'s board?
Odyssey Therapeutics Inc.'s board has 11 directors: Aranicki Ksenija Pavletic, Carolyn Ng, Gary D. Glick, Ian F. Smith, Jeffrey M. Leiden, Nan (Ln) Li, Ourania Tatsis, Paulina Hill, Shelley Chu, Timothy P. Walbert and 1 other.
Are Odyssey Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Odyssey Therapeutics Inc. insiders bought $75.3 million of shares in 9 purchases and sold $32,040 of shares in 3 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="odyssey-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.